Influence of Craniosacral Therapy on Anxiety, Depression and Quality of Life in Patients with Fibromyalgia

Table 4

Differences between study groups in Pittsburgh sleep quality index at 6 months and 1 year after treatment.

	6 months (n = number of patients)						P	1 year (n = number of patients)						P
	IG			PG			2(a)-PT	IG			PG			3(a)-PT
PSQI	NP	MP	SP	NP	MP	SP		NP	MP	SP	NP	MP	SP
PSQ	5	13	25	7	18	16	.093	4	11	28	6	19	16	.054
SL	4	18	21	2	14	25	.105	2	18	23	3	14	24	.132
SD	2	16	25	3	7	31	.039*	1	17	25	2	6	33	.040*
HSE	4	19	20	0	14	27	.047*	2	20	21	0	13	28	.044*
SDI	0	21	22	4	11	26	.045*	0	19	24	2	13	26	.088
DD	6	21	16	0	24	17	.240	3	18	22	1	28	12	.039*

Values are shown as n = number of patients with no problems, moderate problems, severe problems. PSQI, Pittsburgh sleep quality index; IG, intervention group; PG, placebo group; Pre-T, pre-therapy; 2(a) PT, post-therapy at 6 months after end of treatment; 3(a) PT, post-therapy at 1 year after end of treatment; PSQ, Pittsburgh subjective quality; SL, sleep latency; SD, sleep duration; HSE, habitual sleep efficiency; SDI, sleep disturbance; DD, daily dysfunction; NP, does not present problems; MP, moderate problems; SP, severe problems. *P = .05 (95% CI).